doc. MUDr. Daniela Žáčková, Ph.D.
Associate professor, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 2838, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 218
2019
-
The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview
Leukemia, year: 2019
-
Život s diagnózou: Chronická myeloidní leukemie
Year: 2019, type: R&D Presentation
2018
-
Analysis of serum lipids, cardiovascular risk and indication for statin therapy at the start and during imatinib and nilotinib therapy in de novo CML patients, results from real life prosective study
Year: 2018, type: Conference abstract
-
Analýza sérových lipidů, kardiovaskulárního rizika a indikace k hypolipidemické terapii u nemocných s de novo CML léčených imatinibem - výsledky z prospektivní studie
Year: 2018, type: Conference abstract
-
CML - Understanding your diagnosis
Year: 2018, type: R&D Presentation
-
Considerations for Treatment-free Remission in Patients With Chronic Myeloid Leukemia: A Joint Patient-Physician Perspective
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, year: 2018, volume: 18, edition: 6, DOI
-
Dasatinib v léčbě chronické myeloidní leukemie s těžkou jaterní toxicitou předchozí léčby imatinibem
Year: 2018, type: Popularization text
-
Chronická myeloidní leukemie a pět léků – který vybrat? Nebo žádný?
Year: 2018, type:
-
Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy
American Journal of Hematology, year: 2018, volume: 93, edition: 10, DOI
-
Is There a Safe haven to Stop TKIs in CML? CML and Ph+ALL - State of the Art: Expert panel No 003 Prague, December 2017
Aktuální témata v onkologii očima českých lékařů, year: 2018, volume: 2018, edition: 3